【ChiCTR2100043254】short term outcomes for one stage and two stage basilic vein trans positioning (BVT) in patients with small cephalic vein caliber
ChiCTR2100043254
结束
/
/
/
2021-02-09
/
/
chronic renal failure
short term outcomes for one stage and two stage basilic vein trans positioning (BVT) in patients with small cephalic vein caliber
short term outcomes for one stage and two stage basilic vein trans positioning (BVT) in patients with small cephalic vein caliber
to compare the short term outcomes of one stage and two stage basilic vein transpositioning in patients with small caliber cephalic veins
连续入组
探索性研究/预试验
no randomization
N/A
no funding source
/
150
/
2008-12-13
2020-08-13
/
all small caliber cephalic vein chronic renal failure patients with failed previous primary vascular access;
请登录查看patients undergoing primary vascular access or who were found to have good size vessels on operation table upon exploration contrary to venous mapping;
请登录查看no sponser
/
no sponser的其他临床试验
- short term outcomes for one stage and two stage basilic vein trans positioning (BVT) in patients with small cephalic vein caliber
- delayed presentation of acute limb ischemia: a sinister
- Transpositioning of basilic vein for vascular acess for the hemodialysis: An experience of a tertiary care hospital
- Association of Body Mass Index and diet with Symptomatic Gall Stone Disease: A Case-Control Study
巴基斯坦伊斯兰堡shifa tameer-e-millat university的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
